Medtronic Patent Award Reduced

A federal court has reduced the amount Boston Scientific must pay Medtronic for patent violations from $250 million to $19 million, reports the Boston Globe. The U.S. District Court in Marshall, TX also invalidated two of the three Medtronic patents that Boston Scientific had been found to have violated. The patents concerned stent technology. A Texas jury had determined the $250 million award in May. Boston Scientific said it will appeal the $19 million award to the U.S.